Repaglinide + Octreotide Interaction
Moderateinteraction on record
Description
Somatostatin analog that may increase risk of hypoglycemia. Repaglinide dose reductions and increased glucose monitoring may be required.
Mechanism
Increased hypoglycemia risk
Source: NLP:repaglinide